Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Tóm tắt
Từ khóa
Tài liệu tham khảo
World Health Report 2002: Reducing risks promoting healthy life. Geneva Switzerland: World Health Organization 2002. http://www.who.int/whr/2002.
U. S. Department of Health and Human Services National Heart Lung and Blood Institute. National High Blood Pressure Education Program. Available at: http://www.nhlbi.nih.gov/about/nhbpep/index.htm. Accessed November 2003.
Roccella E Kaplan N. Interpretation and evaluation of clinical guidelines. In: Izzo JL Jr Black HR (eds). Hypertension Primer: The Essentials of High Blood Pressure: Basic Science Population Science and Clinical Management. Philadelphia PA: Lippincott Williams & Wilkins; 2003. pp. 126–127. PR
Last JM Abramson JH. A Dictionary of Epidemiology. 3rd ed. New York NY: Oxford University Press; 1995.
Shaughnessy AF, Slawson DC, Bennett JH. Becoming an information master: a guidebook to the medical information jungle. J Fam Pract. 1994; 39: 489–499. PR
Delbecq A Van de Ven A Gustafson D. Group Techniques for Program Planning: A Guide to Nominal Group and Delphi Process. Glenview IL: Scott Foresman; 1975. PR
Hyman DJ, Pavlik VN, Vallbona C. Physician role in lack of awareness and control of hypertension. J Clin Hypertens (Greenwich). 2000; 2: 324–330.X
Cleveland LE Goldman JD Borrud LG. Data tables: results from USDA’s 1994 continuing survey of food intakes by individuals and 1994 diet and health knowledge survey. Riverdale MD: Agricultural Research Service US Department of Agriculture. 1996.http://www.barc.usda.gov/bhnrc/foodsurvey/pdf/Tbs1994.pdf
U S Department of Health and Human Services. Physical activity and health: a report of the Surgeon General. Atlanta GA: US Department of Health and Human Services Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion. 1996. http://www.cdc.gov/nccdphp/sgr/contents.htm PR
Division of Adult and Community Health National Center for Chronic Disease Prevention and Health Promotion Centers for Disease Control and Prevention. 5 a day surveillance: behavioral risk factor surveillance system online prevalence data 1995–2000. Available at: http://apps.nccd.cdc.gov/5ADaySurveillance./ Accessed November 2003.
American Public Health Association. 2002–4 Reducing sodium content in the American diet. Association News. 2002; 5–6.
National High Blood Pressure Education Program. Summary report: the National High Blood Pressure Education Program Coordinating Committee meeting. Bethesda MD: National High Blood Pressure Education Program National Heart Lung and Blood Institute; 2002. pp. 1–37. http://www.nhlbi.nih.gov/about/nhbpep/nhbp_abs.htm
Office of Disease Prevention and Health Promotion US Department of Health and Human Services. Healthy People 2010. Available at: http://www.healthypeople.gov./ Accessed November 2003.
US Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute. Facts about the DASH eating plan. Available at http://www.nhlbi.nih.gov/health/public/heart/hbp/dash/index.htm. Accessed November 2003.
National Heart Lung and Blood Institute. Your guide to lowering high blood pressure. Available at http://www.nhlbi.nih.gov/hbp/index.html. Accessed November 2003.
US Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute National High Blood Pressure Education Program. National High Blood Pressure Education Month. Available at: http://hin.nhlbi.nih.gov/nhbpep_kit./ Accessed November 2003.
US Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute. The heart truth: a national awareness campaign for women about heart disease. Available at: http://www.nhlbi.nih.gov/health/hearttruth/index.htm. Accessed November 2003.
National Institutes of Health National Heart Lung and Blood Institute Office of Prevention Education and Control. Mobilizing African American communities to address disparities in cardiovascular health: The Baltimore City Health Partnership Strategy Development Workshop. Summary report. Available at: http://www.nhlbi.nih.gov/health/prof/heart/other/balt_rpt.htm. Accessed November 2003.
US Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute. NHLBI Healthy People 2010 Gateway. Available at: http://hin.nhlbi.nih.gov./ Accessed November 2003.
National Heart Lung and Blood Institute. Cardiovascular disease enhanced dissemination and utilization centers (EDUCs) awardees. Available at: http://hin.nhlbi.nih.gov/educs/awardees.htm. Accessed November 2003.
National Institutes of Health National Heart Lung and Blood Institute. Hearts N’ Parks. Available at: http://www.nhlbi.nih.gov/health/prof/heart/obesity/hrt_n_pk/index.htm. Accessed November 2003.
National Institutes of Health. Healthbeat radio network. Available at: http://radiospace.com/healthbeat.htm. Accessed November 2003.
National Heart Lung and Blood Institute. Salud para su Corazón (For the Health of Your Heart). Available at: http://www.nhlbi.nih.gov/health/prof/heart/latino/salud.htm. Accessed November 2003.
National Institutes of Health. Mad as a hatter? Join our campaign for a mercury free NIH. Available at: http://www.nih.gov/od/ors/ds/nomercury./ Accessed November 2003.
Working Meeting on Blood Pressure Measurement: Summary Report. Available at: http://www.nhlbi.nih.gov/health/prof/heart/hbp/bpmeasu.pdf. Accessed November 2003.
World Hypertension League. Measuring your blood pressure. Available at: http://www.mco.edu/org/whl/bloodpre.html. Accessed November 2003.
Pickering TG, Coats A, Mallion JM, Mancia G, Verdecchia P. Blood Pressure Monitoring. Task force V: White-coat hypertension. Blood Press Monit. 1999; 4: 333–341. PR
GFR /1.73 M2 by MDRD (± SUN and SAlb) Calculator. Available at: http://www.hdcn.com/calcf/gfr.htm. Accessed November 2003.
Pohl MA. Renovascular hypertension and ischemic nephropathy. In: Wilcox CS (ed): Atlas of Diseases of the Kidney. Philadelphia PA: Developed by Current Medicine Inc.; 1999.
Biglieri EG. Primary aldosteronism. Curr Ther Endocrinol Metab. 1997; 6: 170–172.
Cooper-DeHoff RM, Bristol HA, Pepine CJ. Ethnic differences in systolic blood pressure control in hypertensive patients with coronary artery disease. Am J Hypertens. 2003; 16: 27A.
Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. Writing Group of the PREMIER Collaborative Research Group. JAMA. 2003; 289: 2083–2093. RA
Chalmers J, Zanchetti A. The 1996 report of a World Health Organization expert committee on hypertension control. J Hypertens. 1996; 14: 929–933. PR
Tepper D. Frontiers in congestive heart failure: effect of Metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). MERIT-HF Study Group. Congest Heart Fail. 1999; 5: 184–185. RA
The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993; 342: 821–828. RA
Rosendorff C. Treatment of hypertension patients with ischemic heart disease. In: Izzo JL Jr Black HR (eds): Hypertension Primer: The Essentials of High Blood Pressure: Basic Science Population Science and Clinical Management. Philadelphia PA: Lippincott Williams & Wilkins; 2003. pp. 456–459. PR
Chrysant GS Oparil S. Treatment of hypertension in the patient with cardiovascular disease. In: Antman EM (ed): Cardiovascular Therapeutics: A Companion to Braunwald’s Heart Disease. Philadelphia PA: WB Saunders; 2001. pp. 768–795. PR
American Heart Association. Heart disease and stroke statistics-2003 update. Dallas TX: American Heart Association; 2002.
Prevalence of Diabetes and Impaired Fasting Glucose in Adults-United States, 1999–2000. Morbidity and Mortality Weekly Report. 2003; 52: 833–837.
Collins AJ, Kasiske B, Herzog C, Chen S-C, Everson S, Constantini E, et al. Excerpts from the United States Renal Data System 2001 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Am J Kidney Dis. 2001; 38: S7–S247.
Assman G, Cullen P, Schulte H. The Munster Heart Study (PROCAM): results of follow-up at 8 years. Eur Heart J. 1998; 19: A2–A11. F
Sowers JR, Reed J. 1999 clinical advisory: treatment of hypertension and diabetes. J Clin Hypertens (Greenwich). 2000; 2: 132–133. PR
National Heart Lung and Blood Institute. Strong Heart Study Data Book: A Report to American Indians Communities. Bethesda MD: National Institutes of Health National Heart Lung and Blood Institute. NIH Publication No. 01–3285 2001. pp. 19. http://www.nhlbi.nih.gov/resources/docs/shs_db.pdf
Crespo CJ, Loria CM, Burt VL. Hypertension and other cardiovascular disease risk factors among Mexican Americans, Cuban Americans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey. Public Health Rep. 1996; 111: 7–10.
U S Department of Health and Human Services. Understanding and improving health and objectives for improving health. Healthy People 2010. Washington DC: United States Government Printing Office; 2000. pp. 19–31.
Lawrence J Stockbridge N Hung HMJ Chi G. Joint statistical-clinical review: NDA resubmission dated 14 December 2001 including the results of the OCTAVE study. FDA Center for Drug Evaluation and Research Division of Cardio-Renal Drug Products. NDA: 21–188 (omapatrilat for hypertension) June 2002. pp. 1–31. http://www.fda.gov/ohrms/dockets/ac/02/briefing/3877B2_03_FDA-Medial-Statistical.doc
Wilson PWF, D’Agostino RB, Parise H, Meigs JB. The metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Diabetes. 2002; 51: A242. F
Gidding SS, Falkner B. Are we losing the game? Cardiovascular health in minority children. Ethn Dis. 2002; 12: 171–173.
Devereux R. Management of hypertensive patients with left ventricular hypertrophy and diastolic dysfunction. In: Izzo J Jr Black H (eds): Hypertension Primer: The Essentials of High Blood Pressure: Basic Science Population Science and Clinical Management. Philadelphia PA: Lippincott Williams & Wilkins; 2003. pp. 460–463.
Haynes WG Lopez JAG Mark AL. Treatment of hypertension combined with cardiovascular disease. In: Smith TW (ed): Cardiovascular Therapeutics: A Companion to Braunwald’s Heart Disease. Philadelphia PA: WB Saunders; 1996. pp. 503–504. PR
Olin JW. Treatment of hypertensive patients with peripheral arterial disease. In: Izzo JL Jr Black HR (eds): Hypertension Primer: The Essentials of High Blood Pressure: Basic Science Population Science and Clinical Management. Philadelphia PA: Lippincott Williams & Wilkins; 2003. pp. 467–469.
U S. Census Bureau. Persons 65 Years Old and Over-Characteristics by Sex: 1980 to 2000. Statistical Abstracts of the United States: 2002. Washington DC: U S Census Bureau; 2001. pp. 43.
Spence JD, Sibbald WJ, Cape RD. Pseudohypertension in the elderly. Clin Sci Mol Med Suppl. 1978; 55: 399s–402s. C
Nally J Jr. Management of renovascular hypertension. In: Izzo J Jr Black H (eds): Hypertension Primer: The Essentials of High Blood Pressure: Basic Science Population Science and Clinical Management. Philadelphia PA: Lippincott Williams & Wilkins; 2003. pp. 500–502.
Oster JR, Materson BJ. Pseudohypertension: a diagnostic dilemma. J Clin Hypertens. 1986; 4: 307–313.
Staessen J, Bulpitt CJ, Fagard R, Lijnen P, Amery A. The influence of menopause on blood pressure. J Hum Hypertens. 1989; 3: 427–433. RA
Calhoun DA Oparil S. Gender and blood pressure. In: Izzo JL Jr Black HR (eds): Hypertension Primer: The Essentials of High Blood Pressure: Basic Science Population Science and Clinical Management. Philadelphia PA: Lippincott Williams & Wilkins; 2003. pp. 253–257. PR
Taler SJ. Treatment of pregnant hypertensive patients. In: Izzo JL Jr Black HR (eds): Hypertension Primer: The Essentials of High Blood Pressure: Basic Science Population Science and Clinical Management. Philadelphia PA: Lippincott Williams & Wilkins; 2003. pp. 491–493. PR
ACOG Practice Bulletin. Chronic hypertension in pregnancy. ACOG Committee on Practice Bulletins. Obstet Gynecol. 2001; 98: 177–185. PR
Calhoun DA. Hypertensive crisis. In: Oparil S Weber MA (eds): Hypertension: A Companion to Brenner and Recot’s The Kidney. Philadelphia PA: WB Saunders Co.; 2000. pp. 715–718. PR
Vidt DG. Management of hypertensive urgencies and emergencies. In: Izzo JL Jr Black HR (eds): Hypertension Primer: The Essentials of High Blood Pressure. Dallas TX: American Heart Association; 1999. pp. 437–440. PR
Vidt DG. Treatment of hypertensive emergencies and urgencies. In: Izzo JL Jr Black HR Goodfriend TL (eds): Hypertension Primer: The Essentials of High Blood Pressure: Basic Science Population Science and Clinical Management. Philadelphia PA: Lippincott Williams & Wilkins; 2003. pp. 452–459. PR
Alper A Calhoun D. Hypertensive emergencies. In: Antman EM (ed): Cardiovascular Therapeutics: A Companion to Braunwald’s Heart Disease. Philadelphia PA: WB Saunders Co; 2002. pp. 817–831. PR
Morgan BJ. Pathophysiology of sleep apnea. In: Izzo JL Jr Black H (eds): Hypertension Primer: The Essentials of High Blood Pressure: Basic Science Population Science and Clinical Management. Philadelphia PA: Lippincott Williams & Wilkins; 2003. pp. 156–158. PR
Somers VK. Management of sleep apnea. In: Izzo JL Jr Black HR (eds): Hypertension Primer: The Essentials of High Blood Pressure: Basic Science Population Science and Clinical Management. Philadelphia PA: Lippincott Williams & Wilkins; 2003. pp. 512–516. PR
American Academy of Ophthalmology. Basic and Clinical Science Course Section 12 1999–2000. San Francisco CA: American Academy of Ophthalmology; 1999. pp. 68–70.
Textor SC. Hypertension and transplantation. In: Izzo JL Jr Black HR (eds): Hypertension Primer: The Essentials of High Blood Pressure: Basic Science Population Science and Clinical Management. Philadelphia PA: Lippincott Williams & Wilkins; 2003. pp. 163–165. PR
Canzanello VJ. Management of posttransplant hypertension. In: Izzo JL Jr Black HR (eds): Hypertension Primer: The Essentials of High Blood Pressure: Basic Science Population Science and Clinical Management. Philadelphia PA: Lippincott Williams & Wilkins; 2003. pp. 519–522. PR
Textor SC. Renal failure related to angiotensin-converting enzyme inhibitors. Semin Nephrol. 1997; 17: 67–76. PR
Sos TA. Angioplasty for the treatment of azotemia and renovascular hypertension in atherosclerotic renal artery disease. Circulation. 1991; 83 (Suppl I): I-162–I-166. F
Sowers JR, White WB, Pitt B, Whelton A, Simon L, van Ingen H, et al. Rofecoxib, but not celecoxib or naproxen, increases mean 24-hour systolic blood pressure in treated hypertensive patients with osteoarthritis and type 2 diabetes mellitus. J Am Coll Cardiol. 2003; 41: 320A. RA
Herzlinger RE. Market-Driven Health Care: Who Wins Who Loses in the Transformation of America’s Largest Service Industry. Reading MA: Addison-Wesley Publishing Co; 1997. pp. 65–75 231.
Maue SK, Rivo ML, Weiss B, Farrelly EW, Brower-Stenger S. Effect of a primary care physician-focused, population-based approach to blood pressure control. Fam Med. 2002; 34: 508–513. F
Bandura A. Social Learning Theory. Englewood Cliffs NJ: Prentice Hall; 1977.